Further, IPMK KO resulted in enhanced LCV inhibition of HIV-1 infection in a dose-dependent manner (Fig. 2A and B), suggesting that IP5 and IP6 counter the antiviral activity of LCV. Here, IPMK is linked to HIV-1 infection.